| RS1131692023 |
MMAA
|
Health Risk |
Likely pathogenic |
— |
| RS1131692024 |
COL3A1
|
Health Risk |
Likely pathogenic |
— |
| RS1131692025 |
DNM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 31A |
| RS1131692026 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1131692028 |
DNM1
|
Health Risk |
Likely pathogenic |
— |
| RS1131692029 |
PHEX
|
Health Risk |
Likely pathogenic |
— |
| RS1131692030 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1131692031 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1131692032 |
NDUFS1
|
Health Risk |
Likely pathogenic |
— |
| RS1131692034 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1131692035 |
BRCA2
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS1131692036 |
ELOVL4
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 34, Spinocerebellar ataxia type 34 |
| RS1131692037 |
MRPS34
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Combined oxidative phosphorylation deficiency 32 |
| RS1131692039 |
CHD7
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 5 with or without anosmia, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1131692040 |
RPL10
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS1131692041 |
RPL10
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS1131692042 |
RPL10
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS1131692043 |
YY1
|
Health Risk |
Pathogenic |
Gabriele de Vries syndrome, Gabriele de Vries syndrome |
| RS1131692044 |
YY1
|
Health Risk |
Pathogenic |
Gabriele de Vries syndrome, Gabriele de Vries syndrome |
| RS1131692045 |
YY1
|
Health Risk |
Pathogenic |
Gabriele de Vries syndrome, Gabriele de Vries syndrome |
| RS1131692046 |
YY1
|
Health Risk |
Pathogenic |
Gabriele de Vries syndrome, Gabriele de Vries syndrome |
| RS1131692047 |
NKX6-2
|
Health Risk |
Pathogenic |
Spastic ataxia 8, autosomal recessive |
| RS1131692048 |
NKX6-2
|
Health Risk |
Pathogenic |
Spastic ataxia 8, autosomal recessive |
| RS1131692049 |
FBN1
|
Health Risk |
Pathogenic |
MASS syndrome, MASS syndrome |
| RS1131692050 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Marfan syndrome |
| RS1131692052 |
FBN1
|
Health Risk |
Pathogenic |
Acromicric dysplasia, Acromicric dysplasia |
| RS1131692053 |
MAP3K1
|
Health Risk |
Pathogenic |
46, XY sex reversal 6 |
| RS1131692054 |
PTPRF
|
Health Risk |
Pathogenic |
Breasts and/or nipples, aplasia or hypoplasia of |
| RS1131692055 |
PAX2
|
Health Risk |
Pathogenic |
Focal segmental glomerulosclerosis 7, Focal segmental glomerulosclerosis 7 |
| RS1131692056 |
PRKCB
|
Health Risk |
Pathogenic |
Progressive sensorineural hearing impairment, Progressive sensorineural hearing impairment |
| RS1131692057 |
PAX9
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS1131692058 |
BRAF
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy 4 |
| RS1131692059 |
ESR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Estrogen resistance syndrome, Estrogen resistance syndrome |
| RS1131692060 |
COL4A5
|
Health Risk |
Likely pathogenic |
Familial hematuria, Familial hematuria |
| RS1131692065 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1131692086 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1131692093 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1131692098 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1131692107 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1131692109 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1131692115 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1131692117 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1131692119 |
BRCA2
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1131692137 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1131692146 |
HPS5
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 5, Hermansky-Pudlak syndrome 5 |
| RS1131692147 |
HPS5
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 5, Hermansky-Pudlak syndrome 5 |
| RS1131692148 |
HPS5
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 5, Hermansky-Pudlak syndrome 5 |
| RS1131692149 |
HPS5
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 5, Hermansky-Pudlak syndrome 5 |
| RS1131692150 |
HPS5
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 5, Hermansky-Pudlak syndrome 5 |
| RS1131692151 |
HPS5
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 5, Hermansky-Pudlak syndrome 5 |
| RS1131692152 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS1131692153 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1131692154 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 5 |
| RS1131692155 |
OGT
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 106 |
| RS1131692156 |
ABCA12
|
Health Risk |
Likely pathogenic |
Autosomal recessive congenital ichthyosis 4B, Autosomal recessive congenital ichthyosis 4B |
| RS1131692158 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1131692159 |
KIF1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 9 |
| RS1131692161 |
CSNK2B
|
Health Risk |
Pathogenic |
Intellectual disability and seizures, Poirier-Bienvenu neurodevelopmental syndrome |
| RS1131692162 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast neoplasm |
| RS1131692163 |
YY1
|
Health Risk |
Pathogenic |
Gabriele de Vries syndrome, Gabriele de Vries syndrome |
| RS1131692164 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1131692165 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1131692166 |
PANK2
|
Health Risk |
Likely pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1131692167 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1131692169 |
MCM5
|
Health Risk |
Pathogenic |
Meier-Gorlin syndrome 8, Meier-Gorlin syndrome 8 |
| RS1131692170 |
ERAL1
|
Health Risk |
Pathogenic |
Perrault syndrome 6, Perrault syndrome |
| RS1131692171 |
NBAS
|
Health Risk |
Pathogenic |
Short stature-optic atrophy-Pelger-Huët anomaly syndrome, Short stature-optic atrophy-Pelger-Huët anomaly syndrome |
| RS1131692173 |
EED
|
Health Risk |
Likely pathogenic |
Cohen-Gibson syndrome, Cohen-Gibson syndrome |
| RS1131692174 |
EED
|
Health Risk |
Pathogenic |
Cohen-Gibson syndrome, Cohen-Gibson syndrome |
| RS1131692175 |
EED
|
Health Risk |
Pathogenic |
Cohen-Gibson syndrome, Cohen-Gibson syndrome |
| RS1131692176 |
EED
|
Health Risk |
Pathogenic |
Cohen-Gibson syndrome, Cohen-Gibson syndrome |
| RS1131692177 |
SUZ12
|
Health Risk |
Pathogenic |
Imagawa-Matsumoto syndrome, Imagawa-Matsumoto syndrome |
| RS1131692180 |
TMEM107
|
Health Risk |
Pathogenic |
Meckel syndrome 13, Meckel syndrome 13 |
| RS1131692181 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS1131692182 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 3, Monogenic diabetes |
| RS1131692183 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome 2, Long QT syndrome |
| RS1131692184 |
EZH2
|
Health Risk |
Likely pathogenic |
Weaver syndrome, Weaver syndrome |
| RS1131692185 |
FLNC
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 26, Hypertrophic cardiomyopathy 26 |
| RS1131692186 |
MAP3K1
|
Health Risk |
Pathogenic |
46, XY sex reversal 6 |
| RS1131692187 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young |
| RS1131692189 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692190 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692191 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692192 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692193 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692194 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1131692195 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692196 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1131692197 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692198 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692201 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692202 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692203 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692204 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692205 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692206 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692208 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692209 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692210 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692211 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |